

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle tissue regeneration (GO:0043403) | 9.36441476 |
| 2 | muscle filament sliding (GO:0030049) | 9.04929632 |
| 3 | actin-myosin filament sliding (GO:0033275) | 9.04929632 |
| 4 | negative regulation of skeletal muscle tissue development (GO:0048642) | 8.69574003 |
| 5 | regulation of skeletal muscle contraction (GO:0014819) | 8.39015702 |
| 6 | response to muscle activity (GO:0014850) | 7.90968495 |
| 7 | actin-mediated cell contraction (GO:0070252) | 7.31379527 |
| 8 | cellular response to dexamethasone stimulus (GO:0071549) | 6.02825634 |
| 9 | response to activity (GO:0014823) | 5.83766154 |
| 10 | response to dexamethasone (GO:0071548) | 5.55612845 |
| 11 | striated muscle adaptation (GO:0014888) | 5.16710016 |
| 12 | dosage compensation (GO:0007549) | 5.03806155 |
| 13 | actin filament-based movement (GO:0030048) | 4.87758832 |
| 14 | protein K6-linked ubiquitination (GO:0085020) | 4.87700254 |
| 15 | response to testosterone (GO:0033574) | 4.50053128 |
| 16 | protein trimerization (GO:0070206) | 4.39119200 |
| 17 | regulation of muscle hypertrophy (GO:0014743) | 4.38034725 |
| 18 | muscle adaptation (GO:0043500) | 4.25070783 |
| 19 | positive regulation of histone H3-K4 methylation (GO:0051571) | 4.20952856 |
| 20 | skeletal muscle contraction (GO:0003009) | 4.15132544 |
| 21 | regulation of relaxation of muscle (GO:1901077) | 4.13277357 |
| 22 | negative regulation of organelle assembly (GO:1902116) | 3.96440911 |
| 23 | cellular response to glucocorticoid stimulus (GO:0071385) | 3.66986032 |
| 24 | regulation of centriole replication (GO:0046599) | 3.60269280 |
| 25 | response to electrical stimulus (GO:0051602) | 3.53868951 |
| 26 | cellular response to corticosteroid stimulus (GO:0071384) | 3.44511556 |
| 27 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.42369886 |
| 28 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.31673710 |
| 29 | cytidine deamination (GO:0009972) | 3.30837093 |
| 30 | cytidine metabolic process (GO:0046087) | 3.30837093 |
| 31 | cytidine catabolic process (GO:0006216) | 3.30837093 |
| 32 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.30765990 |
| 33 | tissue regeneration (GO:0042246) | 3.29199995 |
| 34 | myotube cell development (GO:0014904) | 3.29146428 |
| 35 | negative regulation of muscle tissue development (GO:1901862) | 3.27727073 |
| 36 | negative regulation of striated muscle tissue development (GO:0045843) | 3.25613466 |
| 37 | muscle organ development (GO:0007517) | 3.21014436 |
| 38 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.14077580 |
| 39 | muscle structure development (GO:0061061) | 3.13870878 |
| 40 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 3.12035240 |
| 41 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.09694556 |
| 42 | heparin biosynthetic process (GO:0030210) | 3.07348072 |
| 43 | heparin metabolic process (GO:0030202) | 3.07348072 |
| 44 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.07252262 |
| 45 | regulation of gene expression by genetic imprinting (GO:0006349) | 3.06649320 |
| 46 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.06393944 |
| 47 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.04561180 |
| 48 | positive regulation of mast cell degranulation (GO:0043306) | 3.04561180 |
| 49 | protein polyglutamylation (GO:0018095) | 3.01527241 |
| 50 | negative regulation of muscle organ development (GO:0048635) | 3.00716757 |
| 51 | DNA deamination (GO:0045006) | 2.99679117 |
| 52 | negative regulation of histone acetylation (GO:0035067) | 2.97147182 |
| 53 | muscle system process (GO:0003012) | 2.92088583 |
| 54 | cullin deneddylation (GO:0010388) | 2.92031643 |
| 55 | protein deneddylation (GO:0000338) | 2.83191034 |
| 56 | purine nucleotide salvage (GO:0032261) | 2.82172216 |
| 57 | muscle contraction (GO:0006936) | 2.81093205 |
| 58 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 2.77831660 |
| 59 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.73509146 |
| 60 | response to inactivity (GO:0014854) | 2.72288922 |
| 61 | cellular response to ketone (GO:1901655) | 2.72116636 |
| 62 | regulation of DNA methylation (GO:0044030) | 2.69536362 |
| 63 | regulation of histone H3-K9 methylation (GO:0051570) | 2.69181207 |
| 64 | skeletal muscle fiber development (GO:0048741) | 2.66050674 |
| 65 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.64143677 |
| 66 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.62404109 |
| 67 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.61748731 |
| 68 | ATP synthesis coupled proton transport (GO:0015986) | 2.61328096 |
| 69 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.61328096 |
| 70 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.60652633 |
| 71 | negative regulation of protein acetylation (GO:1901984) | 2.59208249 |
| 72 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.58802153 |
| 73 | regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108) | 2.57358972 |
| 74 | behavioral response to nicotine (GO:0035095) | 2.56386186 |
| 75 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.55003847 |
| 76 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.55003847 |
| 77 | regulation of hypersensitivity (GO:0002883) | 2.54649342 |
| 78 | regulation of germinal center formation (GO:0002634) | 2.53994973 |
| 79 | cellular ketone body metabolic process (GO:0046950) | 2.53184077 |
| 80 | adenosine metabolic process (GO:0046085) | 2.49322852 |
| 81 | negative regulation of histone methylation (GO:0031061) | 2.45957974 |
| 82 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.44993133 |
| 83 | positive regulation of mast cell activation (GO:0033005) | 2.44394451 |
| 84 | hair cycle (GO:0042633) | 2.42582600 |
| 85 | molting cycle (GO:0042303) | 2.42582600 |
| 86 | positive regulation of DNA repair (GO:0045739) | 2.38326668 |
| 87 | protein-cofactor linkage (GO:0018065) | 2.36449790 |
| 88 | regulation of sarcomere organization (GO:0060297) | 2.33481257 |
| 89 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.32086146 |
| 90 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.29825917 |
| 91 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.28244243 |
| 92 | postreplication repair (GO:0006301) | 2.27566794 |
| 93 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.26951848 |
| 94 | negative regulation of cell killing (GO:0031342) | 2.26951848 |
| 95 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.25148565 |
| 96 | response to gravity (GO:0009629) | 14.3648309 |
| 97 | skeletal muscle adaptation (GO:0043501) | 12.4602271 |
| 98 | striated muscle atrophy (GO:0014891) | 12.1393524 |
| 99 | muscle atrophy (GO:0014889) | 11.1643326 |
| 100 | negative regulation of muscle hypertrophy (GO:0014741) | 10.1307573 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_22108803_ChIP-Seq_LS180_Human | 7.95358024 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.41396975 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.58056868 |
| 4 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 4.09593127 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.99520255 |
| 6 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 3.08128445 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.88866559 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.80330847 |
| 9 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.76037459 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.72095751 |
| 11 | FUS_26573619_Chip-Seq_HEK293_Human | 2.67183514 |
| 12 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.35126098 |
| 13 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.32319527 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.28207302 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.23489546 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.07504115 |
| 17 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.04614798 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.90590852 |
| 19 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.89206075 |
| 20 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.80887756 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.78754335 |
| 22 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.78377016 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.74112681 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.71839334 |
| 25 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.70727908 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55133406 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.52918560 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.49876784 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.48596528 |
| 30 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.36396800 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35932235 |
| 32 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.34216881 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.33731705 |
| 34 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.33634488 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.32557116 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24100622 |
| 37 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.23863098 |
| 38 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.23220004 |
| 39 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.22336362 |
| 40 | AR_20517297_ChIP-Seq_VCAP_Human | 1.19847129 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.17631625 |
| 42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17250981 |
| 43 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.16977496 |
| 44 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15677484 |
| 45 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12998265 |
| 46 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09898342 |
| 47 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09898342 |
| 48 | KDM2B_26808549_Chip-Seq_REH_Human | 1.09633099 |
| 49 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.06901220 |
| 50 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.06701242 |
| 51 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.06412486 |
| 52 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.06112336 |
| 53 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.05972603 |
| 54 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05784947 |
| 55 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05550541 |
| 56 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04762081 |
| 57 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.04644968 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.04320784 |
| 59 | EWS_26573619_Chip-Seq_HEK293_Human | 0.99903621 |
| 60 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99510454 |
| 61 | MYB_26560356_Chip-Seq_TH2_Human | 0.98857056 |
| 62 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.98120927 |
| 63 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.97102199 |
| 64 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.96857620 |
| 65 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.96727162 |
| 66 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.95410918 |
| 67 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95274825 |
| 68 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95104256 |
| 69 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94690091 |
| 70 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.94512344 |
| 71 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.94492736 |
| 72 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.93988489 |
| 73 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.93968179 |
| 74 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.93968179 |
| 75 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93773176 |
| 76 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93628781 |
| 77 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.93353636 |
| 78 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.93152455 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91610817 |
| 80 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91595231 |
| 81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.91261541 |
| 82 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.90889301 |
| 83 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.90874569 |
| 84 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.90597555 |
| 85 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.89826708 |
| 86 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.89697441 |
| 87 | TCF4_23295773_ChIP-Seq_U87_Human | 0.88996959 |
| 88 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.87248527 |
| 89 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86567319 |
| 90 | GATA3_26560356_Chip-Seq_TH1_Human | 0.86468500 |
| 91 | NCOR_22424771_ChIP-Seq_293T_Human | 0.85528680 |
| 92 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.84127765 |
| 93 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.83883713 |
| 94 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83569640 |
| 95 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82741315 |
| 96 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.81752966 |
| 97 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.81564150 |
| 98 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.80881562 |
| 99 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.80798401 |
| 100 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.80163838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 5.93366641 |
| 2 | MP0000747_muscle_weakness | 5.37595437 |
| 3 | MP0004036_abnormal_muscle_relaxation | 4.27030356 |
| 4 | MP0002269_muscular_atrophy | 3.59023246 |
| 5 | MP0002089_abnormal_postnatal_growth/wei | 3.55756908 |
| 6 | MP0000749_muscle_degeneration | 3.26073944 |
| 7 | MP0000759_abnormal_skeletal_muscle | 3.00712619 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 3.00198856 |
| 9 | MP0005083_abnormal_biliary_tract | 2.70872315 |
| 10 | MP0002108_abnormal_muscle_morphology | 2.66595063 |
| 11 | MP0002736_abnormal_nociception_after | 2.61851513 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.39671931 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.27200235 |
| 14 | MP0002106_abnormal_muscle_physiology | 2.26074390 |
| 15 | MP0004087_abnormal_muscle_fiber | 2.23128560 |
| 16 | MP0004147_increased_porphyrin_level | 2.21051174 |
| 17 | MP0000566_synostosis | 2.04470412 |
| 18 | MP0003646_muscle_fatigue | 2.02457642 |
| 19 | MP0005646_abnormal_pituitary_gland | 1.99589937 |
| 20 | MP0003959_abnormal_lean_body | 1.97498367 |
| 21 | MP0003786_premature_aging | 1.96797873 |
| 22 | MP0005671_abnormal_response_to | 1.96328593 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.87161349 |
| 24 | MP0002102_abnormal_ear_morphology | 1.83270572 |
| 25 | MP0005369_muscle_phenotype | 1.82554891 |
| 26 | MP0006072_abnormal_retinal_apoptosis | 1.78970017 |
| 27 | MP0002638_abnormal_pupillary_reflex | 1.73381321 |
| 28 | MP0001661_extended_life_span | 1.73328620 |
| 29 | MP0000372_irregular_coat_pigmentation | 1.69355657 |
| 30 | MP0002095_abnormal_skin_pigmentation | 1.63968550 |
| 31 | MP0003724_increased_susceptibility_to | 1.63425777 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.54067538 |
| 33 | MP0003045_fibrosis | 1.51217957 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.48918915 |
| 35 | MP0005645_abnormal_hypothalamus_physiol | 1.42140280 |
| 36 | MP0005670_abnormal_white_adipose | 1.40525349 |
| 37 | MP0000427_abnormal_hair_cycle | 1.37010863 |
| 38 | MP0004885_abnormal_endolymph | 1.35922272 |
| 39 | MP0000733_abnormal_muscle_development | 1.35122312 |
| 40 | MP0004084_abnormal_cardiac_muscle | 1.30931711 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.29782771 |
| 42 | MP0008995_early_reproductive_senescence | 1.21149098 |
| 43 | MP0001243_abnormal_dermal_layer | 1.18308525 |
| 44 | MP0004142_abnormal_muscle_tone | 1.16889933 |
| 45 | MP0008872_abnormal_physiological_respon | 1.16515598 |
| 46 | MP0004484_altered_response_of | 1.13351478 |
| 47 | MP0001986_abnormal_taste_sensitivity | 1.08301334 |
| 48 | MP0003787_abnormal_imprinting | 0.98564433 |
| 49 | MP0000751_myopathy | 0.97228041 |
| 50 | MP0002896_abnormal_bone_mineralization | 0.93667247 |
| 51 | MP0004130_abnormal_muscle_cell | 0.92308300 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 0.92256547 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 0.92125129 |
| 54 | MP0003950_abnormal_plasma_membrane | 0.91181939 |
| 55 | MP0002723_abnormal_immune_serum | 0.90657139 |
| 56 | MP0004043_abnormal_pH_regulation | 0.90131688 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 0.89531400 |
| 58 | MP0002166_altered_tumor_susceptibility | 0.88642799 |
| 59 | MP0003880_abnormal_central_pattern | 0.88318039 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 0.88301397 |
| 61 | MP0008875_abnormal_xenobiotic_pharmacok | 0.84609086 |
| 62 | MP0001800_abnormal_humoral_immune | 0.84121993 |
| 63 | MP0000750_abnormal_muscle_regeneration | 0.83954776 |
| 64 | MP0001905_abnormal_dopamine_level | 0.83854144 |
| 65 | MP0001502_abnormal_circadian_rhythm | 0.83366532 |
| 66 | MP0001765_abnormal_ion_homeostasis | 0.82950262 |
| 67 | MP0008877_abnormal_DNA_methylation | 0.82102845 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 0.80679876 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 0.79255440 |
| 70 | MP0009250_abnormal_appendicular_skeleto | 0.79061573 |
| 71 | MP0004215_abnormal_myocardial_fiber | 0.78480375 |
| 72 | MP0004270_analgesia | 0.78078211 |
| 73 | MP0003763_abnormal_thymus_physiology | 0.76651753 |
| 74 | MP0005000_abnormal_immune_tolerance | 0.75265505 |
| 75 | MP0003937_abnormal_limbs/digits/tail_de | 0.73734561 |
| 76 | MP0001486_abnormal_startle_reflex | 0.72758638 |
| 77 | MP0009780_abnormal_chondrocyte_physiolo | 0.72399619 |
| 78 | MP0005253_abnormal_eye_physiology | 0.72250982 |
| 79 | MP0000467_abnormal_esophagus_morphology | 0.72145070 |
| 80 | MP0000631_abnormal_neuroendocrine_gland | 0.71874840 |
| 81 | MP0000685_abnormal_immune_system | 0.69009699 |
| 82 | MP0009745_abnormal_behavioral_response | 0.67392877 |
| 83 | MP0002148_abnormal_hypersensitivity_rea | 0.67174816 |
| 84 | MP0002733_abnormal_thermal_nociception | 0.66809087 |
| 85 | MP0001501_abnormal_sleep_pattern | 0.66661230 |
| 86 | MP0002822_catalepsy | 0.65337747 |
| 87 | MP0005360_urolithiasis | 0.64975291 |
| 88 | MP0005334_abnormal_fat_pad | 0.64942717 |
| 89 | MP0002006_tumorigenesis | 0.64694296 |
| 90 | MP0005423_abnormal_somatic_nervous | 0.63147436 |
| 91 | MP0008775_abnormal_heart_ventricle | 0.61588965 |
| 92 | MP0001819_abnormal_immune_cell | 0.61573590 |
| 93 | MP0008789_abnormal_olfactory_epithelium | 0.61464014 |
| 94 | MP0002115_abnormal_skeleton_extremities | 0.60665358 |
| 95 | MP0002452_abnormal_antigen_presenting | 0.60118628 |
| 96 | MP0002396_abnormal_hematopoietic_system | 0.59881833 |
| 97 | MP0002420_abnormal_adaptive_immunity | 0.59070067 |
| 98 | MP0003866_abnormal_defecation | 0.59031830 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.56348796 |
| 100 | MP0005452_abnormal_adipose_tissue | 0.55350578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Palpebral edema (HP:0100540) | 8.67986561 |
| 2 | Distal arthrogryposis (HP:0005684) | 7.14940067 |
| 3 | Nemaline bodies (HP:0003798) | 7.04114952 |
| 4 | Round ear (HP:0100830) | 6.13038781 |
| 5 | Exercise-induced myalgia (HP:0003738) | 6.09304749 |
| 6 | Absent phalangeal crease (HP:0006109) | 6.04423948 |
| 7 | Mask-like facies (HP:0000298) | 5.99739457 |
| 8 | Muscle fiber inclusion bodies (HP:0100299) | 5.66049231 |
| 9 | Ulnar deviation of the wrist (HP:0003049) | 5.65344621 |
| 10 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.60594197 |
| 11 | Calcaneovalgus deformity (HP:0001848) | 5.22688918 |
| 12 | Abnormal finger flexion creases (HP:0006143) | 5.19901507 |
| 13 | Deformed tarsal bones (HP:0008119) | 5.00817731 |
| 14 | Periorbital edema (HP:0100539) | 4.67260689 |
| 15 | Hyperkalemia (HP:0002153) | 4.58466612 |
| 16 | Facial edema (HP:0000282) | 4.48791151 |
| 17 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.14781945 |
| 18 | Abnormality of alanine metabolism (HP:0010916) | 4.14781945 |
| 19 | Hyperalaninemia (HP:0003348) | 4.14781945 |
| 20 | Myopathic facies (HP:0002058) | 4.06906895 |
| 21 | Type 1 muscle fiber predominance (HP:0003803) | 3.98154729 |
| 22 | Myoglobinuria (HP:0002913) | 3.59259772 |
| 23 | Exercise-induced muscle cramps (HP:0003710) | 3.26538220 |
| 24 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.15717504 |
| 25 | Myotonia (HP:0002486) | 3.11903660 |
| 26 | Oligomenorrhea (HP:0000876) | 2.93757022 |
| 27 | Nonprogressive disorder (HP:0003680) | 2.91621897 |
| 28 | Decreased circulating renin level (HP:0003351) | 2.91094224 |
| 29 | Abnormality of potassium homeostasis (HP:0011042) | 2.84563107 |
| 30 | Rhabdomyolysis (HP:0003201) | 2.78028224 |
| 31 | IgG deficiency (HP:0004315) | 2.75481182 |
| 32 | 3-Methylglutaconic aciduria (HP:0003535) | 2.73842813 |
| 33 | Neoplasm of the heart (HP:0100544) | 2.65495150 |
| 34 | Fibular aplasia (HP:0002990) | 2.55501238 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.42490780 |
| 36 | Constricted visual fields (HP:0001133) | 2.38743007 |
| 37 | Conical tooth (HP:0000698) | 2.34056115 |
| 38 | Abnormality of the calcaneus (HP:0008364) | 2.33167502 |
| 39 | Congenital stationary night blindness (HP:0007642) | 2.32263970 |
| 40 | Increased connective tissue (HP:0009025) | 2.30590924 |
| 41 | Abnormality of the prostate (HP:0008775) | 2.28283696 |
| 42 | Stenosis of the external auditory canal (HP:0000402) | 2.26792937 |
| 43 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.23942962 |
| 44 | Maternal diabetes (HP:0009800) | 2.15695197 |
| 45 | Stomatitis (HP:0010280) | 2.11625835 |
| 46 | Metabolic acidosis (HP:0001942) | 2.10287143 |
| 47 | Mesomelia (HP:0003027) | 2.06658286 |
| 48 | Abnormality of the parietal bone (HP:0002696) | 2.06432632 |
| 49 | Abnormality of the peritoneum (HP:0002585) | 2.05149111 |
| 50 | Increased purine levels (HP:0004368) | 2.04094430 |
| 51 | Hyperuricemia (HP:0002149) | 2.04094430 |
| 52 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.01616191 |
| 53 | Type 2 muscle fiber atrophy (HP:0003554) | 1.98044230 |
| 54 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.96697100 |
| 55 | Pigmentary retinal degeneration (HP:0001146) | 1.95845973 |
| 56 | Poor speech (HP:0002465) | 1.94276635 |
| 57 | Hypokalemia (HP:0002900) | 1.94134373 |
| 58 | Toxemia of pregnancy (HP:0100603) | 1.93349815 |
| 59 | Metatarsus adductus (HP:0001840) | 1.92128314 |
| 60 | Difficulty running (HP:0009046) | 1.88500071 |
| 61 | 2-3 toe syndactyly (HP:0004691) | 1.83823674 |
| 62 | Abnormality of the columella (HP:0009929) | 1.83186451 |
| 63 | Malignant hyperthermia (HP:0002047) | 1.83105435 |
| 64 | Hyperphosphatemia (HP:0002905) | 1.82767312 |
| 65 | Congenital sensorineural hearing impairment (HP:0008527) | 1.82598102 |
| 66 | Supernumerary ribs (HP:0005815) | 1.82315680 |
| 67 | Muscle stiffness (HP:0003552) | 1.81606462 |
| 68 | Down-sloping shoulders (HP:0200021) | 1.81391822 |
| 69 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.79927614 |
| 70 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.79536790 |
| 71 | Hypoplastic iliac wings (HP:0002866) | 1.78632573 |
| 72 | Stomach cancer (HP:0012126) | 1.78374911 |
| 73 | Renal cortical cysts (HP:0000803) | 1.77385999 |
| 74 | Abolished electroretinogram (ERG) (HP:0000550) | 1.77376145 |
| 75 | Hypoproteinemia (HP:0003075) | 1.73129183 |
| 76 | Bell-shaped thorax (HP:0001591) | 1.69639695 |
| 77 | Tarsal synostosis (HP:0008368) | 1.69536968 |
| 78 | Decreased subcutaneous fat (HP:0001002) | 1.69307763 |
| 79 | Abnormality of chloride homeostasis (HP:0011422) | 1.66928909 |
| 80 | Abnormality of purine metabolism (HP:0004352) | 1.62917292 |
| 81 | Hyperglycemia (HP:0003074) | 1.62081499 |
| 82 | Abnormal drinking behavior (HP:0030082) | 1.61905837 |
| 83 | Polydipsia (HP:0001959) | 1.61905837 |
| 84 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.59097886 |
| 85 | Congenital, generalized hypertrichosis (HP:0004540) | 1.59094431 |
| 86 | Fatigue (HP:0012378) | 1.58565986 |
| 87 | Paralysis (HP:0003470) | 1.57244458 |
| 88 | Cerebral palsy (HP:0100021) | 1.56500387 |
| 89 | Abnormality of macular pigmentation (HP:0008002) | 1.55104544 |
| 90 | Pulmonary embolism (HP:0002204) | 1.54111487 |
| 91 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.53222778 |
| 92 | Synostosis involving bones of the feet (HP:0009140) | 1.53222778 |
| 93 | Hypoalphalipoproteinemia (HP:0003233) | 1.52978744 |
| 94 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.49411062 |
| 95 | Attenuation of retinal blood vessels (HP:0007843) | 1.49211195 |
| 96 | Prostate neoplasm (HP:0100787) | 1.48337761 |
| 97 | Muscle fiber atrophy (HP:0100295) | 1.48101524 |
| 98 | Generalized aminoaciduria (HP:0002909) | 1.47693276 |
| 99 | Short phalanx of the thumb (HP:0009660) | 1.47153802 |
| 100 | Abnormality of the renal cortex (HP:0011035) | 1.46236559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PHKG2 | 4.38614667 |
| 2 | PHKG1 | 4.38614667 |
| 3 | TIE1 | 4.16650003 |
| 4 | OBSCN | 3.67141008 |
| 5 | TXK | 2.96782525 |
| 6 | TLK1 | 2.92283606 |
| 7 | MAP4K2 | 2.86866643 |
| 8 | JAK3 | 2.57544436 |
| 9 | WNK4 | 2.44656772 |
| 10 | SCYL2 | 2.42828583 |
| 11 | MAP3K12 | 2.39839490 |
| 12 | NUAK1 | 2.31113746 |
| 13 | WNK1 | 1.81967963 |
| 14 | TAOK3 | 1.77218936 |
| 15 | ADRBK2 | 1.66140274 |
| 16 | PIK3CA | 1.63826591 |
| 17 | CAMKK2 | 1.60302769 |
| 18 | BCKDK | 1.51969863 |
| 19 | IRAK1 | 1.49642642 |
| 20 | ZAK | 1.46394383 |
| 21 | MAPK13 | 1.42176540 |
| 22 | TYRO3 | 1.41339911 |
| 23 | MAP4K1 | 1.40495295 |
| 24 | BMPR2 | 1.39030861 |
| 25 | TEC | 1.38196059 |
| 26 | PINK1 | 1.31650993 |
| 27 | FES | 1.29799129 |
| 28 | MAP2K2 | 1.28674814 |
| 29 | MUSK | 1.22473229 |
| 30 | CCNB1 | 1.19468802 |
| 31 | TESK2 | 1.13446078 |
| 32 | TRPM7 | 1.12422387 |
| 33 | GRK6 | 1.10961600 |
| 34 | PIK3CG | 1.09141296 |
| 35 | STK16 | 1.07352465 |
| 36 | LIMK1 | 1.05317422 |
| 37 | MAP3K14 | 1.02728651 |
| 38 | GRK1 | 1.01361931 |
| 39 | MYLK | 1.00915283 |
| 40 | ITK | 0.98650869 |
| 41 | CHEK2 | 0.94315024 |
| 42 | CDK4 | 0.94155396 |
| 43 | FRK | 0.93304992 |
| 44 | EIF2AK2 | 0.92337509 |
| 45 | OXSR1 | 0.90883254 |
| 46 | CAMK2G | 0.90385512 |
| 47 | KIT | 0.90128844 |
| 48 | CAMK1D | 0.89637097 |
| 49 | FGFR2 | 0.83777775 |
| 50 | CSNK1G2 | 0.82260990 |
| 51 | MST4 | 0.78235685 |
| 52 | CSF1R | 0.76203880 |
| 53 | DAPK2 | 0.75112078 |
| 54 | IKBKB | 0.72666439 |
| 55 | MAPK7 | 0.71419926 |
| 56 | CSNK1G1 | 0.71259557 |
| 57 | EIF2AK3 | 0.71197900 |
| 58 | SYK | 0.69204939 |
| 59 | AURKA | 0.68253502 |
| 60 | ILK | 0.68108975 |
| 61 | CASK | 0.67061250 |
| 62 | STK39 | 0.66860738 |
| 63 | PDK2 | 0.65216902 |
| 64 | CSNK1A1L | 0.64995174 |
| 65 | INSRR | 0.64359779 |
| 66 | CSNK1G3 | 0.61467420 |
| 67 | PRKG1 | 0.57681827 |
| 68 | DYRK2 | 0.55911530 |
| 69 | DAPK1 | 0.55716749 |
| 70 | MAPKAPK3 | 0.52627287 |
| 71 | FGFR3 | 0.51634505 |
| 72 | MARK3 | 0.50138945 |
| 73 | BTK | 0.48013063 |
| 74 | RPS6KA5 | 0.47484935 |
| 75 | PIM1 | 0.45270945 |
| 76 | PRKCE | 0.44459951 |
| 77 | SGK1 | 0.40024887 |
| 78 | LCK | 0.39901968 |
| 79 | MAPK12 | 0.39691645 |
| 80 | IGF1R | 0.39503314 |
| 81 | PRKCQ | 0.39455250 |
| 82 | DYRK1B | 0.38451590 |
| 83 | MAP2K3 | 0.37708963 |
| 84 | IKBKE | 0.37175639 |
| 85 | CAMK1 | 0.34994417 |
| 86 | ADRBK1 | 0.33207536 |
| 87 | CDK19 | 0.32753772 |
| 88 | VRK2 | 0.32498075 |
| 89 | SGK2 | 0.32348919 |
| 90 | SGK223 | 0.32176143 |
| 91 | SGK494 | 0.32176143 |
| 92 | ERBB3 | 0.31878124 |
| 93 | CAMK1G | 0.31473815 |
| 94 | EPHA3 | 0.30861378 |
| 95 | LYN | 0.30738362 |
| 96 | KDR | 0.29235628 |
| 97 | FLT3 | 0.29070792 |
| 98 | CAMKK1 | 0.28978915 |
| 99 | ABL1 | 0.28862301 |
| 100 | PAK6 | 0.28184250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 5.05878782 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.66320926 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.49344180 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.38491512 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.25111160 |
| 6 | Regulation of autophagy_Homo sapiens_hsa04140 | 3.07962253 |
| 7 | Tight junction_Homo sapiens_hsa04530 | 2.66008657 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.63746544 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.53001261 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.48071883 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.35890871 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.31408488 |
| 13 | Ribosome_Homo sapiens_hsa03010 | 2.05463313 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.72170100 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.61084118 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.59743593 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.57975682 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.57557443 |
| 19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.41137574 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.36626026 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.33488516 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 1.30131055 |
| 23 | RNA degradation_Homo sapiens_hsa03018 | 1.29634259 |
| 24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.25364675 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.21290089 |
| 26 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.21098282 |
| 27 | Circadian rhythm_Homo sapiens_hsa04710 | 1.19595905 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.19309278 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.18783533 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.13904996 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.05539917 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.05478137 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.01292205 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.00284445 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.00185639 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98730688 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94603012 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93456507 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93326032 |
| 40 | Olfactory transduction_Homo sapiens_hsa04740 | 0.93076498 |
| 41 | Spliceosome_Homo sapiens_hsa03040 | 0.92091226 |
| 42 | Phototransduction_Homo sapiens_hsa04744 | 0.90483934 |
| 43 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90318084 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.85745744 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83839514 |
| 46 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.79833355 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.79546679 |
| 48 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.78719480 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76988470 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76436780 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 0.73051407 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70809048 |
| 53 | Nicotine addiction_Homo sapiens_hsa05033 | 0.69493878 |
| 54 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.69450636 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.69188564 |
| 56 | Salivary secretion_Homo sapiens_hsa04970 | 0.68405196 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66791393 |
| 58 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66556590 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64755107 |
| 60 | Taste transduction_Homo sapiens_hsa04742 | 0.64229889 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60804468 |
| 62 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59708558 |
| 63 | Basal transcription factors_Homo sapiens_hsa03022 | 0.57981460 |
| 64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.56336510 |
| 65 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54884615 |
| 66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.54008858 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.53462846 |
| 68 | RNA polymerase_Homo sapiens_hsa03020 | 0.53384171 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53349758 |
| 70 | Huntingtons disease_Homo sapiens_hsa05016 | 0.52191297 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51378245 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50345653 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.48867799 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47153713 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46830646 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46030103 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45664933 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45639419 |
| 79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45121678 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44499051 |
| 81 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.43713919 |
| 82 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43377740 |
| 83 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.42141824 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41314334 |
| 85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37758552 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.36864664 |
| 87 | RNA transport_Homo sapiens_hsa03013 | 0.35015017 |
| 88 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.34820586 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34210219 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34180079 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.30249594 |
| 92 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.29136240 |
| 93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28572534 |
| 94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27301306 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.26915567 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26216968 |
| 97 | Measles_Homo sapiens_hsa05162 | 0.25709910 |
| 98 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.23952071 |
| 99 | Homologous recombination_Homo sapiens_hsa03440 | 0.23535265 |
| 100 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.23529233 |

